Health Catalyst, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Health Catalyst, Inc. on December 2, 2025, covering events occurring on December 1, 2025. The filing primarily addresses corporate governance changes, specifically the appointment of a new director and the non-renomination of an existing director.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses on governance and does not contain financial performance data.
Material Changes
- Board Expansion and Appointment: The Board expanded from eight to nine directors effective December 1, 2025. Mathew (Matt) Arens was appointed to fill the new seat as a Class I director.
- Shareholder Agreement: A letter agreement was executed between the Company, First Light Asset Management, LLC (the Company's largest stockholder), and Mr. Arens. This agreement includes voting and confidentiality commitments.
- Ownership Stake: First Light and Mr. Arens collectively own approximately 13.9 million shares, representing approximately 19% of the Company's outstanding common stock.
- Director Departure: The Board determined not to renominate Matthew Kolb for the 2026 annual meeting. Mr. Kolb agreed not to stand for re-election. His term will end immediately prior to the 2026 annual meeting.
- Board Size Reduction: The Board approved a reduction in size from nine to eight directors, effective immediately prior to the 2026 annual meeting of stockholders.
Guidance, Outlook, and Management Commentary
There is no financial guidance or outlook provided in this filing. Management commentary is limited to the rationale for the board changes:
- Mr. Arens was appointed based on the recommendation of the Nominating and Corporate Governance Committee.
- Mr. Arens has waived all compensation for his board service except for the reimbursement of out-of-pocket expenses.
- There were no disagreements between Mr. Kolb and the Company regarding operations, policies, or practices that led to his decision not to seek re-election.
Investor Verification Checklist
- Verify the terms of the letter agreement between Health Catalyst, First Light, and Matt Arens (Exhibit 10.1).
- Confirm the exact timing of the Board size reduction relative to the 2026 annual meeting.
- Review the press release issued on December 2, 2025 (Exhibit 99.1) for additional context on the governance changes.
- Monitor the 2026 annual meeting proxy statement for the election of the new Class I director to replace Mr. Kolb.